Principal Financial Group Inc Oncternal Therapeutics, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.7 - $1.56 $22,369 - $49,851	-31,956 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.37 - $2.43 $22,278 - $39,516	-16,262 Reduced 33.73%	31,956 $44,000
Q4 2021 Feb 09, 2022	SELL	$2.27 - $4.39 $82,589 - $159,721	-36,383 Reduced 43.01%	48,218 $109,000
Q3 2021 Nov 09, 2021	SELL	$3.37 - $4.76 $7,228 - $10,210	-2,145 Reduced 2.47%	84,601 $353,000
Q2 2021 Aug 10, 2021	BUY	$4.75 - $9.39 $412,043 - $814,544	86,746 New	86,746 $412,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.